Altogether, these results demonstrate that BAFF neutralization attenuated partial recovery of glucose dysmetabolism at 20 weeks after HFD and promoted liver steatosis in the C57BL/6J mice. The gene discussed is TNFSF13B; the disease is fatty liver disease.